ahlam1399
02-25-2016, 03:22 PM
AstraZeneca?s $4 bln Acerta deal endorsed by orphan drug status
LONDON, Feb 25 (Reuters) - AstraZeneca's bold moveto buy 55 percent of privately held biotech firm Acerta Pharmafor $4 billion in December has been vindicated, at least inpart, by the award of...http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=6d2zyTgjZQs:ZY5spIuTp-Q:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=6d2zyTgjZQs:ZY5spIuTp-Q:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=6d2zyTgjZQs:ZY5spIuTp-Q:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=6d2zyTgjZQs:ZY5spIuTp-Q:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=6d2zyTgjZQs:ZY5spIuTp-Q:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/6d2zyTgjZQs
LONDON, Feb 25 (Reuters) - AstraZeneca's bold moveto buy 55 percent of privately held biotech firm Acerta Pharmafor $4 billion in December has been vindicated, at least inpart, by the award of...http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=6d2zyTgjZQs:ZY5spIuTp-Q:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=6d2zyTgjZQs:ZY5spIuTp-Q:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=6d2zyTgjZQs:ZY5spIuTp-Q:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=6d2zyTgjZQs:ZY5spIuTp-Q:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=6d2zyTgjZQs:ZY5spIuTp-Q:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/6d2zyTgjZQs